IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.464
AS - Asia 2.209
EU - Europa 1.518
SA - Sud America 345
AF - Africa 94
OC - Oceania 1
Totale 6.631
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.398
CN - Cina 861
SG - Singapore 534
VN - Vietnam 305
HK - Hong Kong 288
BR - Brasile 262
IE - Irlanda 260
RU - Federazione Russa 233
DE - Germania 199
IT - Italia 177
FR - Francia 129
FI - Finlandia 120
GB - Regno Unito 113
UA - Ucraina 102
ZA - Sudafrica 59
SE - Svezia 57
IN - India 55
CA - Canada 42
AR - Argentina 28
BD - Bangladesh 25
BE - Belgio 19
IQ - Iraq 19
NL - Olanda 19
PL - Polonia 18
AT - Austria 17
EC - Ecuador 16
MX - Messico 15
TR - Turchia 15
PH - Filippine 13
CZ - Repubblica Ceca 12
ES - Italia 11
JP - Giappone 11
PK - Pakistan 11
VE - Venezuela 10
CO - Colombia 9
ID - Indonesia 9
UZ - Uzbekistan 9
MA - Marocco 8
SA - Arabia Saudita 8
CH - Svizzera 7
CL - Cile 7
LT - Lituania 7
PY - Paraguay 6
TN - Tunisia 6
JO - Giordania 5
KE - Kenya 5
LB - Libano 5
MY - Malesia 5
DK - Danimarca 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
ET - Etiopia 3
IL - Israele 3
MU - Mauritius 3
NP - Nepal 3
QA - Qatar 3
BB - Barbados 2
BY - Bielorussia 2
DZ - Algeria 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KR - Corea 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
MZ - Mozambico 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 6.631
Salva come PNG Salva come JPEG
Città #
San Jose 295
Singapore 276
Hong Kong 273
Dublin 260
Chandler 244
Ashburn 239
Dallas 211
Beijing 208
Nanjing 151
Jacksonville 100
Ho Chi Minh City 98
Boardman 85
Lauterbourg 84
Ann Arbor 78
Hanoi 74
Los Angeles 73
Redondo Beach 63
Munich 61
Helsinki 60
New York 56
Johannesburg 48
Lawrence 45
Princeton 45
Medford 44
Moscow 42
Nanchang 42
Dearborn 40
Shanghai 39
Wilmington 34
Shenyang 32
São Paulo 32
Changsha 30
Buffalo 27
Houston 27
Turku 24
Jiaxing 23
Hebei 22
Council Bluffs 21
Frankfurt am Main 21
Brussels 19
Da Nang 19
Orem 19
Toronto 19
Pavia 18
Tianjin 18
Milan 17
Nuremberg 17
Vinnytsia 17
Rome 16
The Dalles 16
Amsterdam 15
Brooklyn 15
Falkenstein 15
Montesilvano Marina 15
Chongqing 14
Hangzhou 14
London 14
Phoenix 14
Piemonte 14
Warsaw 14
Woodbridge 14
Chicago 13
Haiphong 12
Kunming 11
Santa Clara 11
Stockholm 11
Tokyo 11
Montreal 10
Redwood City 10
Washington 10
Atlanta 9
Chennai 9
Denver 9
Vienna 9
Guangzhou 8
Norwalk 8
Poplar 8
Tashkent 8
Ankara 7
Basingstoke 7
Des Moines 7
Jinan 7
Turin 7
Baghdad 6
Biên Hòa 6
Düsseldorf 6
Fairfield 6
Hefei 6
Hyderabad 6
Hải Dương 6
New Delhi 6
Rio de Janeiro 6
Seattle 6
Zhengzhou 6
Belo Horizonte 5
Bologna 5
Brasília 5
Caracas 5
Charlotte 5
Fortaleza 5
Totale 4.278
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 170
Lyosecretome for use in the treatment of autoimmune diseases 139
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 137
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 136
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 134
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 134
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 133
Expression of receptor for advanced glycation end products in sarcoid granulomas. 117
A regulatory SNP in the Promoter Region of the RAGE Gene 116
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 115
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 113
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 113
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 113
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 109
Identification and characterisation of eight novel SERPINA1 null mutations. 109
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 106
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 105
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 105
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 105
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 100
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 100
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 98
α₁-Antitrypsin level and pheno/genotypes 97
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 97
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 96
Alpha-1 antitrypsin deficiency: From the lung to the heart? 96
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 92
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 88
COPD: no gene left unturned 88
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 85
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 85
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 84
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 82
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 82
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 82
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 82
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 79
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 79
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 78
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 78
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 75
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 72
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 72
Update on α1-antitrypsin deficiency 70
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 69
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 69
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 67
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 67
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 67
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 66
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 64
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 63
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 62
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 59
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 59
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 59
α1-Antitrypsin deficiency. 58
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 57
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 57
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 57
Recommendations for the measurement of the most important plasma proteins 54
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 53
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 53
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 53
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 53
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 53
Sanger and Next-Generation Sequencing of AAT 52
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 52
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 52
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 50
Complement receptor 1 gene polymorphisms in sarcoidosis. 47
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 47
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 46
How can we improve the detection of Alpha1-antitrypsin deficiency? 45
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 41
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 38
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 38
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 38
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 37
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 36
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 35
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 35
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 33
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients 30
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 30
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 29
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 28
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 27
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 27
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 22
The phenotypic state of bi allelic SERPINA1 Q0 variants in alpha-1 antitrypsin deficiency 22
Alpha-1 antitrypsin deficiency-associated liver disease: A review focusing on new assessment tools and therapies 19
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency 11
Totale 6.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 33 29 24
2021/2022199 6 2 4 5 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/20251.476 20 71 76 90 30 134 57 80 329 70 185 334
2025/20262.932 235 200 322 348 379 158 670 118 317 185 0 0
Totale 6.732